Latest News from: Houston Methodist

Filters close
Released: 1-Aug-2007 8:30 AM EDT
Christopher Reeve Foundation Spinal Cord Injury Research Network Receives DoD Grant
Houston Methodist

A multi-million dollar grant from the United States Department of Defense (DoD) will allow six hospital centers, including the Methodist Neurological Institute (NI), to expand a spinal cord injury research network created by the Christopher Reeve Foundation (CRF). The North American Clinical Trials Network (NACTN) was organized by the CRF to bring promising therapies for spinal cord injury from the laboratory to clinical trials in an effective manner with maximum safety to patients undergoing treatment for their spinal cord injury.

17-Jul-2007 9:00 AM EDT
The Methodist Hospital System Chosen Among Nation’s Most Wired
Houston Methodist

The Methodist Hospital System is one of the nation's most wired systems, according to the 2007 Most Wired Survey and Benchmarking Study. Methodist has ranked in eight of the nine years since this survey began.

Released: 28-Jun-2007 3:00 PM EDT
Does Weight Loss Really Reduce Risk for Heart Attacks?
Houston Methodist

A $2.2 million grant from the National Institutes of Health (NIH) will help researchers at the Methodist DeBakey Heart Center identify how weight loss and lifestyle changes affect the risk for heart disease in obese and diabetic patients, a rapidly-growing group in America.

8-Jun-2007 4:15 PM EDT
Bird Song Study Gives Clues to Human Stuttering
Houston Methodist

This is the first functional MRI study to determine how vocal sounds are represented within the brain of an awake zebra finch, a well-studied animal model of vocal learning. Because of many similarities between birdsong and human speech, this research could lead to a better understanding of the cause of stuttering and other speech problems.

Released: 16-May-2007 3:00 PM EDT
Internationally Acclaimed Bioengineer, Physicist and Inventor Named to Key Roles at the Methodist Hospital and Research Inst.
Houston Methodist

Scientist and inventor Stephen Wong, Ph.D, PE, led teams that developed the first inkjet printer production and the online stock trading system at Charles Schwab.

Released: 9-May-2007 11:00 AM EDT
Stroke Tip Sheet
Houston Methodist

For National Stroke Awareness Month, the Eddy Scurlock Stroke Center at the Methodist Neurological Institute has several story ideas to offer, including research on microbubbles and ultrasound used to destroy clots in stroke patients, and a therapeutic stroke treatment that targets insulin resistance in non-diabetic patients.

4-May-2007 9:05 AM EDT
New Research Highlights Adverse Outcomes Associated with Unapproved Uses of Drug-coated Stents
Houston Methodist

New research demonstrates a higher rate of major adverse cardiac events, such as heart attack and need for a repeat procedure, in patients who fall outside the parameters of the FDA's original approval for use of drug-eluting stents. Reported in today's Journal of the American Medical Association (JAMA).

Released: 12-Mar-2007 4:15 PM EDT
U.S. Heart Surgeon and a Hero in His Native Country Seeks Political Office
Houston Methodist

For more than three decades Houston heart surgeon Dr. Rafael Espada has mended the hearts of his fellow Guatemalans for free. His countrymen have made him a national hero "“ now he is hoping they make him their vice president.

26-Feb-2007 7:00 PM EST
Statin Therapy Cuts Bad Cholesterol Unprecedented 70 Percent
Houston Methodist

Research published today shows that a combination statin therapy lowers bad cholesterol by an unprecedented 70 percent, and has the added benefit of reducing life-threatening inflammation that can lead to heart disease and stroke. This is the biggest drop in bad cholesterol ever seen in a statin clinical trial.

Released: 8-Dec-2006 2:35 PM EST
Media Alert: Experts on FDA Panel on Drug-Eluting Stents
Houston Methodist

Experts from the Methodist DeBakey Heart Center are available to discuss implications of a Food and Drug Administration panel that met this week to consider whether drug-eluting stents (DES), heralded devices that have been implanted in four million Americans to prop open clogged arteries, might cause deadly blood clots.

Released: 8-Dec-2006 6:00 AM EST
Hospital Among First in U.S. to Implant Device Designed to Prevent Blood Clots in Vascular Grafts
Houston Methodist

Surgeons at the Methodist DeBakey Heart Center in Houston were among the first in the U.S. to implant a new vascular graft engineered to reduce the risk of blood clots in patients treated for peripheral arterial disease (PAD), which affects as many as 12 million Americans over the age of 50.

Released: 30-Nov-2006 12:00 AM EST
Health Tip Sheet: The Methodist Hospital, Houston
Houston Methodist

Health feature story ideas: 1) Botox for stroke patients; 2) Erectile dysfunction and heart disease; 3) Minimally-invasive procedure for women with heavy menstrual cycles; 4) Acid reflux affecting the voice

Released: 29-Nov-2006 12:00 AM EST
Novel Suicide Gene Therapy Used to Treat Malignant Brain Tumors
Houston Methodist

Physicians and researchers in the Methodist Neurological Institute (NI) are studying the use of a novel combination of radiation and suicide gene therapy to treat typically stubborn malignant brain tumors.

Released: 20-Nov-2006 3:00 PM EST
Promising Treatment for High Risk Kidney Recipients in First Year Post-Transplant
Houston Methodist

Data presented indicates effectiveness of new treatment for kidney transplant recipients.

Released: 15-Nov-2006 6:20 PM EST
Link Between Obesity and Inflammation Could Lead to New Therapies
Houston Methodist

This is a study involving obesity and inflammation that could lead to new therapies to prevent diabetes and heart disease.

Released: 13-Nov-2006 5:00 PM EST
Methodist Hospital's Holiday Tip Sheet
Houston Methodist

Two holiday-related stories: One is about heartburn and holiday meals, and the other is about deep vein thrombosis, a potentially-fatal condition that can affect travelers.

Released: 13-Nov-2006 12:00 AM EST
Mobile Robots Offer 24/7 Care to Neurosurgical ICU, Stroke Patients
Houston Methodist

Two nearly 6-foot tall, remote-controlled robots are now on staff at The Methodist Hospital in Houston, caring for critically ill patients suffering from stroke or other neurological problems.

11-Oct-2006 5:15 PM EDT
Novel Toxin Contributes to Severe Group A Streptococcus “Flesh-Eating” Infections
Houston Methodist

A novel toxin resembling a snake venom poison contributes to severe group A Streptococcus "flesh-eating" infections. This discovery provides promise for the development of new therapies to treat some forms of these life-threatening infections.

15-Oct-2006 12:40 PM EDT
Transplanted Immune Cells Prolong Life in ALS Studies
Houston Methodist

The immune cells of the spinal cord and brain contribute significantly to prolonging survival in a model of amyotrophic lateral sclerosis (ALS), a progressive neurodegenerative disease that results in paralysis and eventual death, according to a study published today in Proceedings of the National Academy of Sciences U.S.A.

Released: 4-Oct-2006 5:00 PM EDT
Results for Wet Age-Related Macular Degeneration Show Significant Vision Improvements
Houston Methodist

Research conducted by retina surgeons at The Methodist Hospital shows unprecedented improvements in vision in more than one-third of patients treated with Lucentisâ„¢ for wet age-related macular degeneration (AMD), according to findings published in the New England Journal of Medicine.

1-Sep-2006 6:00 AM EDT
Statin Therapy Greatly Reduces Harmful Inflammation and Cholesterol
Houston Methodist

Research conducted at the Methodist DeBakey Heart Center in Houston shows that a combination statin therapy already proven to lower bad cholesterol by a dramatic 70 percent, now has the added benefit of reducing life-threatening inflammation that can lead to heart disease.

Released: 28-Aug-2006 12:00 AM EDT
Computer Assisted Neuro-Rehabilitation Devices Way of the Future
Houston Methodist

Computer-assisted devices can now offer patients an alternative to traditional physical rehabilitation and medical treatment for stroke, brain injuries and spinal cord injuries.

Released: 21-Aug-2006 6:20 PM EDT
Weight Loss and Intimacy-- A Search for Self
Houston Methodist

Patients who undergo significant weight loss often need behavioral and social therapy to address issues around intimacy. This is an aspect of obesity that is rarely discussed.

Released: 8-Aug-2006 2:00 PM EDT
A Medical/Health Tip Sheet
Houston Methodist

A medical/health tip sheet from The Methodist Hospital in Houston, covering topics ranging from a new sinus procedure to software that allows physicians to understand blood flow in the brain.

Released: 10-Jul-2006 1:45 PM EDT
Clinical Trial Studies Stent Grafts to Treat High-Risk Aortic Aneurysms and Tears
Houston Methodist

A clinical trial under way at The Methodist Hospital in Houston is studying the use of stent grafts to treat thoracic aortic aneurysms in high-risk, emergency situations, such as a ruptured aortic aneurysms or tears in the aorta caused by trauma.

Released: 30-Jun-2006 8:40 PM EDT
FDA-approval of Lucentis™ for Wet Age-Related Macular Degeneration
Houston Methodist

Research conducted by retina surgeons at The Methodist Hospital has contributed to FDA approval of a new wonder drug for patients affected by one of the leading causes of blindness in people over 60.

16-Jun-2006 12:00 PM EDT
Biggest Reduction in Bad Cholesterol Ever Achieved in a Clinical Trial
Houston Methodist

Research conducted at the Methodist DeBakey Heart Center in Houston shows a 70 percent reduction in LDL-c, or bad cholesterol, using a combination therapy of two statin drugs. This is the largest reduction in bad cholesterol ever seen in a statin clinical trial.

Released: 24-May-2006 12:00 AM EDT
Study Targets Immune System in Lou Gehrig’s Disease Patients
Houston Methodist

A unique clinical study found only at the Methodist Neurological Institute (NI) in Houston is looking at the benefits of Lipitor on the immune system in patients with Lou Gehrig's disease, or amyotrophic lateral sclerosis (ALS).

Released: 30-Apr-2006 12:45 PM EDT
Novel Combined Therapy for Prostate Cancer Proves Significantly More Effective
Houston Methodist

A five-year follow-up study finds that a combination of radiation and suicide gene therapy is eliminating the spread of prostate cancer and providing a long term vaccine against the disease.

Released: 19-Apr-2006 2:55 PM EDT
Music Therapy to Treat Parkinson’s Disease
Houston Methodist

A unique music therapy study, funded by the GRAMMY Foundation, is underway at the Methodist Neurological Institute (NI) in Houston. Dr. Ron Tintner, a neurologist at the NI and a participating physician in Methodist's Center for Performing Arts Medicine program, is studying music as a way to help treat Parkinson's disease patients.

Released: 22-Mar-2006 1:00 PM EST
Tip Sheet: Stroke Awareness Month
Houston Methodist

1) Investigational neuroprotectant for stroke showing positive signs; 2) Investigational NeuroFlo device for ischemic stroke; 3) Interventional stroke treatment uses first FDA-approved brain stent; 4) Implanted pump targets spasticity in stroke patients

Released: 22-Feb-2006 7:00 AM EST
Methodist Neurosurgeon Makes Quantum Leap on Nano-Level
Houston Methodist

A neurosurgeon at the Methodist Neurological Institute (NI) found a new way to label nanotubes using quantum dots, a discovery that could give researchers a new view into cancer cells, proteins, and DNA molecules.



close
0.16589